COVID-19 and Fatty Liver Disorders
In late 2019, the world was shaken by the COVID-19 pandemic. Severe Acute Respiratory Syndrome Coronavirus—2 (SARS-CoV-2) infection became one of the main causes of illness and hospitalization worldwide, especially in subjects with metabolic comorbidities such as obesity, diabetes, or liver disease....
Main Authors: | Maria Guarino, Valentina Cossiga, Francesco Maria Cutolo, Maria Rosaria Attanasio, Raffaele Lieto, Filomena Morisco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/13/4316 |
Similar Items
-
Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem
by: Sébastien Le Garf, et al.
Published: (2021-12-01) -
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease
by: Patrice Marques, et al.
Published: (2023-01-01) -
A Noninvasive Scoring System for Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
by: Moniyka Sachar, et al.
Published: (2022-01-01) -
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
by: Stefano Ciardullo, et al.
Published: (2021-07-01) -
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
by: Kevan Josloff, et al.
Published: (2022-11-01)